INFARMED, the Portuguese National Authority for Medicines and Health Products, recently granted permission on the supply of narcotic and psychotropic substances and preparations to iBET for research purposes involving the cannabis plant and its derivatives.
The authorisation encompasses the narcotic and psychotropic substances and preparations included in Tables I to IV of Decree-Law 15/93 of 22 January
The demand for medical cannabis is expected to grow all over the world. Research on the potential benefits of cannabis and its derivatives and the development of new solutions is a crucial way to set clear standards and to drive continuous innovation. With the necessary approvals and authorisations, iBET is now leveraging its expertise to deliver R&D support to medical cannabis cultivation industries.
Areas of expertise of Food & Health Division that can support medical cannabis cultivation industries include:
- Phytochemical characterization of Cannabis using different analytical methodologies
- Optimization of green extraction methodologies to obtain bioactive target compounds/extracts
- Purification of target compounds/extracts
- Bioactivity evaluation using pre-clinical assays (antioxidant, anticancer, anti-hyperglycaemic, anti-inflammatory activities)
- Antimicrobial activity